查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225476

視網膜母細胞瘤治療市場：按類型（手術,放射療法,激光療法,冷凍療法,熱療,化療,眼動脈灌注化療,大劑量化療/幹細胞移植）,階段,應用,地區2023-2028

Retinoblastoma Treatment Market by Type(Surgery, Radiation Therapy, Laser Therapy, Cryotherapy, Thermotherapy, Chemotherapy, Opthalmic Artery Infusion Chemotherapy, High-Dose Chemotherapy & Stem Cell Transplant, Staging) Application & Region 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

市場概覽

  • 到 2022 年，全球視網膜母細胞瘤治療市場規模將達到 27 億美元。 展望未來，IMARC Group 預測到 2028 年將達到 35 億美元，2023 年至 2028 年的增長率 (CAGR) 為 4.2%。 眼科治療的醫療費用顯著增加,對副作用較小的治療的研發活動的投資增加以及健康意識的提高是推動市場的一些主要因素。
  • 視網膜母細胞瘤是最常見的癌症之一，通常發生在五歲以下的兒童身上。 視網膜母細胞瘤的症狀包括貓眼反射和稱為白斑的瞳孔混濁。 視網膜母細胞瘤有多種藥物輸送和化學療法，並且由於視網膜母細胞瘤在早期是可以治癒的，因此可以在短時間內見效。 在第一個或第二個化療週期後，可以應用不同的局部治療，具體取決於腫瘤的大小及其在眼內的位置。 不同治療的組合是治療視網膜母細胞瘤最成功的方法。 手術是視網膜母細胞瘤的永久性治療方法，因為它可以將腫瘤從視網膜上完全切除。 視網膜母細胞瘤的詳細診斷包括各種影像學檢查，包括超聲,CT 掃描,MRI,X 射線和骨掃描。

視網膜母細胞瘤治療市場趨勢

  • 用於眼部護理程序的醫療保健支出顯著增加是推動市場發展的一個關鍵因素。 這是由於年輕人視網膜母細胞瘤的發病率上升。 與此同時，增加對副作用更少的更有效治療的研發投資也在振興市場。 此外，對不同類型癌症的認識提高以及診斷和治療率的提高也是重要的增長動力。 然而，各種視網膜母細胞瘤治療的不可用性和嚴格的監管規定正在限制市場的增長。 另一方面，越來越多的產品批准導致新藥上市，給市場帶來了光明的前景。 除此之外，視網膜母細胞瘤復發率的增加也為視網膜母細胞瘤治療市場創造了有利可圖的機會。 此外，主要付款人實施的各種有機增長戰略，如合作夥伴關係,聯盟和併購 (M&A) 正在推動市場。 除此之外，強大的管道藥物的存在和越來越多的臨床試驗正在推動市場增長。 推動市場增長的其他因素包括快速城市化,可支配收入水平上升,癌症研究顯著增加以及全球醫療基礎設施的改善。

主要市場細分

  • IMARC Group 分析了全球視網膜母細胞瘤治療市場每個細分市場的主要趨勢，並提供了 2023 年至 2028 年全球,區域和國家層面的預測。 該報告根據類型,治療類型,分期類型和應用對市場進行細分。

類型洞察

  • 非系視網膜母細胞瘤
  • 遺傳性視網膜母細胞瘤
  • 本報告按類型對視網膜母細胞瘤治療市場進行了詳細細分和分析。 這包括非遺傳性視網膜母細胞瘤和遺傳性視網膜母細胞瘤。 另外，非遺傳性視網膜母細胞瘤佔最大部分。

治療類型見解

  • 手術
  • 放射治療
  • 激光治療（光凝）
  • 冷凍療法
  • 熱療
  • 化療
  • 眼動脈注射化療
  • 大劑量化療和乾細胞移植
  • 本報告根據治療類型對視網膜母細胞瘤治療市場進行了詳細的細分和分析。 這包括手術,放射療法,激光療法（光凝）,冷凍療法,熱療,化學療法,眼動脈注射化學療法,大劑量化學療法和乾細胞移植。 除此之外，化學療法佔最大部分。

暫存見解的類型

  • 眼內視網膜母細胞瘤
  • 眼外視網膜母細胞瘤
  • 本報告根據分期類型對視網膜母細胞瘤治療市場進行了詳細細分和分析。 這包括眼內視網膜母細胞瘤和眼外視網膜母細胞瘤。 根據這份報告，眼內視網膜母細胞瘤佔最大部分。

應用洞察

  • 醫院
  • 癌症研究所
  • 其他
  • 報告還提供了基於應用的視網膜母細胞瘤治療市場的詳細細分和分析。 這包括醫院,癌症研究機構等。

地理洞察

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲
  • 北美（美國,加拿大）,亞太地區（中國,日本,印度,韓國,澳大利亞,印度尼西亞等）,歐洲（德國,法國,英國,意大利,西班牙,俄羅斯等）,南美國（巴西）,墨西哥等）,中東,非洲綜合分析。 除此之外，亞太地區是視網膜母細胞瘤治療的最大市場。 亞太地區視網膜母細胞瘤治療市場的驅動因素是視網膜母細胞瘤的複發率上升，對不同類型癌症的認識提高導致更高的診斷和治療率，以及多個和大公司的存在

本報告中回答的關鍵問題

  • 全球視網膜母細胞瘤治療市場到目前為止表現如何，未來幾年會是什麼樣子？
  • 全球視網膜母細胞瘤治療市場的驅動因素,制約因素和機遇是什麼？
  • 您的主要區域市場是什麼？
  • 哪個國家/地區代表了最具吸引力的視網膜母細胞瘤治療市場？
  • 按類型劃分的市場細分情況如何？
  • 按治療類型劃分的市場細分情況如何？
  • 基於疾病分期的市場細分是什麼？
  • 基於應用的市場細分是什麼？
  • 全球視網膜母細胞瘤治療市場的競爭結構如何？
  • 全球視網膜母細胞瘤治療市場的主要參與者/公司有哪些？

內容

第1章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第4章介紹

  • 概覽
  • 主要行業趨勢

第 5 章全球視網膜母細胞瘤治療市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按類型劃分的市場細分

  • 非干酪性視網膜母細胞瘤
    • 市場趨勢
    • 市場預測
  • 遺傳性視網膜母細胞瘤
    • 市場趨勢
    • 市場預測

第 7 章按治療類型劃分的市場細分

  • 手術
    • 市場趨勢
    • 市場預測
  • 放射治療
    • 市場趨勢
    • 市場預測
  • 激光治療（光凝）
    • 市場趨勢
    • 市場展望
  • 冷凍療法
    • 市場趨勢
    • 市場展望
  • 熱療
    • 市場趨勢
    • 市場預測
  • 化療
    • 市場趨勢
    • 市場預測
  • 眼動脈注射化療
    • 市場趨勢
    • 市場展望
  • 大劑量化療/幹細胞移植
    • 市場趨勢
    • 市場預測

第 8 章按階段類型劃分的市場細分

  • 眼內視網膜母細胞瘤
    • 市場趨勢
    • 市場預測
  • 眼外視網膜母細胞瘤
    • 市場趨勢
    • 市場展望

第 9 章按應用劃分的市場細分

  • 醫院
    • 市場趨勢
    • 市場預測
  • 癌症研究所
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章區域市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 11 章：驅動因素,阻礙因素和機遇

  • 概覽
  • 司機
  • 抑製劑條件
  • 商機

第12章價值鏈分析

第13章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第14章價格分析

第15章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Bristol Myers Squibb Company
    • Pfizer Inc.
    • Teva Canada Limited（Teva Pharmaceutical Industries Ltd.）

本報告所列公司僅為部分，所有公司名稱均包含在本報告中。

Product Code: SR1423A317_Report

Market Overview:

  • The global retinoblastoma treatment market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028. A considerable rise in healthcare expenditure for ophthalmic treatment procedures, increasing investments in research and development (R&D) activities on therapies with lower side effects, and the increasing health consciousness represent some of the key factors driving the market.
  • Retinoblastoma is one of the most common cancers that generally develops before the age of 5 in children. Some of the symptoms of retinoblastoma include a white appearance in the pupil called cat's eye reflex or leukocoria. Retinoblastoma treatment can include a variety of drug delivery and chemotherapy techniques that provide some benefits in the short term since retinoblastoma is curable at the initial stage. Following the first or second chemotherapy cycle, different focal treatments can then be applied depending on how much the tumor shrinks and where it is in the eye. A combination of different treatment methods is the most successful retinoblastoma treatment option. Surgery is the permanent retinoblastoma treatment option as it removes the tumor thoroughly from the retina. There are a variety of imaging tests available for a detailed diagnosis of retinoblastoma, including ultrasound, CT-scan, MRI, X-ray, and bone scan.

Retinoblastoma Treatment Market Trends:

  • A considerable rise in healthcare expenditure for ophthalmic treatment procedures is a significant factor driving the market. This can be attributed to the rising incidences of retinoblastoma among the younger population. In line with this, increasing investments in research and development (R&D) activities focusing on newer, more efficient therapeutic strategies with lesser associated side effects is providing an impetus to the market. Moreover, the growing awareness regarding different type of cancers resulting in higher diagnosis and treatment rates are also acting as a significant growth-inducing factor. However, the lack of availability of various retinoblastoma treatment drugs, along with stringent drug regulations, are acting as a growth-restraining factor for the market. On the contrary, the increasing number of product approvals leading to the launches of new drug variants is creating a positive outlook for the market. Besides this, the growing rates of recurrence of retinoblastoma are also creating lucrative opportunities in the retinoblastoma treatment market. The market is further propelled by various organic growth strategies undertaken by key payers, such as partnerships and collaborations, and merger and acquisitions (M&As). Apart from this, the presence of strong pipeline drugs, along with the augmenting number of clinical trials, are fueling the market growth. Some of the other factors contributing to the market include rapid urbanization, inflating disposable income levels, considerable growth in cancer research, and improvements in medical infrastructure across the globe.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each segment of the global retinoblastoma treatment market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, treatment type, type of staging, and application.

Type Insights:

  • Non-Hereditary Retinoblastoma
  • Hereditary Retinoblastoma
  • The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the type. This includes non-hereditary retinoblastoma and hereditary retinoblastoma. According to the report, non-hereditary retinoblastoma represented the largest segment.

Treatment Type Insights:

  • Surgery
  • Radiation Therapy
  • Laser Therapy (Photocoagulation)
  • Cryotherapy
  • Thermotherapy
  • Chemotherapy
  • Opthalmic Artery Infusion Chemotherapy
  • High-Dose Chemotherapy and Stem Cell Transplant
  • The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the treatment type. This includes surgery, radiation therapy, laser therapy (photocoagulation), cryotherapy, thermotherapy, chemotherapy, opthalmic artery infusion chemotherapy, and high-dose chemotherapy and stem cell transplant. According to the report, chemotherapy represented the largest segment.

Type of Staging Insights:

  • Intraocular Retinoblastoma
  • Extraocular Retinoblastoma
  • The report has provided a detailed breakup and analysis of the retinoblastoma treatment market based on the type of staging. This includes intraocular retinoblastoma and extraocular retinoblastoma. According to the report, intraocular retinoblastoma represented the largest segment.

Application Insights:

  • Hospitals
  • Cancer Institutes
  • Others
  • A detailed breakup and analysis of the retinoblastoma treatment market based on the application has also been provided in the report. This includes hospitals, cancer institutes, and others.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for retinoblastoma treatment. Some of the factors driving the Asia Pacific retinoblastoma treatment market include the growing rates of recurrence of retinoblastoma, higher diagnosis and treatment rates due to the increasing awareness regarding different types of cancers, the presence of several key players in the region, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global retinoblastoma treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bristol Myers Squibb Company, Pfizer Inc., Teva Canada Limited (Teva Pharmaceutical Industries Ltd.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global retinoblastoma treatment market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global retinoblastoma treatment market?
  • What are the key regional markets?
  • Which countries represent the most attractive retinoblastoma treatment markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the type of staging?
  • What is the breakup of the market based on application?
  • What is the competitive structure of the global retinoblastoma treatment market?
  • Who are the key players/companies in the global retinoblastoma treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Retinoblastoma Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Non-Hereditary Retinoblastoma
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hereditary Retinoblastoma
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Radiation Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Therapy (Photocoagulation)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cryotherapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Thermotherapy
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Chemotherapy
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Opthalmic Artery Infusion Chemotherapy
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 High-Dose Chemotherapy and Stem Cell Transplant
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Type of Staging

  • 8.1 Intraocular Retinoblastoma
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Extraocular Retinoblastoma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cancer Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bristol Myers Squibb Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Pfizer Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Teva Canada Limited (Teva Pharmaceutical Industries Ltd.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Retinoblastoma Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Retinoblastoma Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Retinoblastoma Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Retinoblastoma Treatment Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Retinoblastoma Treatment Market: Breakup by Treatment Type (in %), 2022
  • Figure 6: Global: Retinoblastoma Treatment Market: Breakup by Type of Staging (in %), 2022
  • Figure 7: Global: Retinoblastoma Treatment Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Retinoblastoma Treatment Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Retinoblastoma Treatment (Non-Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Retinoblastoma Treatment (Hereditary Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Retinoblastoma Treatment (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Retinoblastoma Treatment (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Retinoblastoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Retinoblastoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Retinoblastoma Treatment (Laser Therapy (Photocoagulation)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Retinoblastoma Treatment (Cryotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Retinoblastoma Treatment (Cryotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Retinoblastoma Treatment (Thermotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Retinoblastoma Treatment (Thermotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Retinoblastoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Retinoblastoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Retinoblastoma Treatment (Opthalmic Artery Infusion Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Retinoblastoma Treatment (High-Dose Chemotherapy and Stem Cell Transplant) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Retinoblastoma Treatment (Intraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Retinoblastoma Treatment (Extraocular Retinoblastoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Retinoblastoma Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Retinoblastoma Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Retinoblastoma Treatment (Cancer Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Retinoblastoma Treatment (Cancer Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Retinoblastoma Treatment (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Retinoblastoma Treatment (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Retinoblastoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Retinoblastoma Treatment Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Retinoblastoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Retinoblastoma Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Retinoblastoma Treatment Industry: Value Chain Analysis
  • Figure 90: Global: Retinoblastoma Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Retinoblastoma Treatment Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Retinoblastoma Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 4: Global: Retinoblastoma Treatment Market Forecast: Breakup by Type of Staging (in Million US$), 2023-2028
  • Table 5: Global: Retinoblastoma Treatment Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Retinoblastoma Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Retinoblastoma Treatment Market: Competitive Structure
  • Table 8: Global: Retinoblastoma Treatment Market: Key Players